April 27th, 2016
With the World Health Organization (WHO) recently declaring the Zika virus a “public health emergency of international concern,” the risk of vector-borne diseases, which are transmitted by insects like mosquitoes, has been catapulted into the global spotlight.
So not surprisingly, the topic was high on the agenda when I joined a group of experts at the International Society of Neglected Tropical Diseases’ annual conference, ISNTD Bites, last month.
Along with sharing the latest research, disease modelling and surveillance technologies, our task was to find ways to promote even greater collaboration between the many parties involved in the control of vector-borne diseases. With many of these diseases—like Zika—emerging rapidly, it’s a huge and on-going challenge.
Facts About the Dengue Virus
I was at the conference to talk about our dengue program, an important part of our commitment to Global Public Health within the Johnson & Johnson Janssen Pharmaceutical Companies.
Much like Zika, dengue is a vector-borne disease that has not been widely known. It’s also a virus that infects nearly 400 million people each year, causing such symptoms as a fever, rash and muscle and joint pain.